Diagnostic Histopathology
Volume 14, Issue 10 , Pages 474-498 , October 2008

Update on pulmonary and pleural lymphoproliferative disorders

References 

  1. Yousem SA. Follicular bronchitis/bronchiolitis. Hum Pathol. 1985;16:700–706
  2. Romero S, Barroso E, Gil J, et al. Follicular bronchiolitis: clinical and pathologic findings in six patients. Lung. 2003;181:309–319
  3. Howling SJ, Hansell DM, Wells AU, et al. Follicular bronchiolitis: thin-section CT and histologic findings. Radiology. 1999;212:637–642
  4. Nicholson AG. Reactive pulmonary lymphoid disorders. Histopathology. 1995;26:405–412
  5. Koss ML, Hochholzer L, Nichols PW, Wehunt WD, Lazarus AA. Primary non-Hodgkin’s lymphoma and pseudolymphoma of the lung. A study of 161 patients. Hum Pathol. 1983;14:1024–1038
  6. Bégueret H, Vergier B, Parrens M, et al. Primary lung small B-cell lymphoma versus lymphoid hyperplasia: evaluation of diagnostic criteria in 26 cases. Am J Surg Pathol. 2002;26:76–81
  7. Iwata M, Sato A. A rat model of chronic bronchiolitis due to Pseudomonas aeruginosa–a histopathological study of bronchus-associated lymphoid tissue (BALT). Kansenshogaku Zasshi. 1990;64:557–563
  8. Davis JK, Cassell GH. Murine respiratory mycoplasmosis in LEW and F344 rats: strain differences in lesion severity. Vet Pathol. 1982;19:280–293
  9. Iwata M, Sato A. Morphological and immunohistochemical studies of the lungs and bronchus-associated lymphoid tissue in a rat model of chronic pulmonary infection with Pseudomonas aeruginosa. Infect Immun. 1991;59:1514–1520
  10. Travis WD, Galvin JR. Non-neoplastic pulmonary lymphoid lesions. Thorax. 2001;56:964–971
  11. Liebow AA, Carrington CB. Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am. 1973;57:809–843
  12. Koss MN, Hochholzer L, Langloss JM, Wehunt WD, Lazarus AA. Lymphoid interstitial pneumonia: clinicopathological and immunopathological findings in 18 cases. Pathology. 1987;19:178–185
  13. Fishback N, Koss M. Update on lymphoid interstitial pneumonitis. Curr Opin Pulm Med. 1996;2:429–433
  14. Swigris JJ, Berry GJ, Raffin TA, Kuschner WG. Lymphoid interstitial pneumonia: a narrative review. Chest. 2002;122:2150–2164
  15. Perreault C, Cousineau S, D’Angelo G, et al. Lymphoid interstitial pneumonia after allogeneic bone marrow transplantation. A possible manifestation of chronic graft-versus-host disease. Cancer. 1985;55:1–9
  16. Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sjogren syndrome. Chest. 2006;130:1489–1495
  17. Uziel Y, Hen B, Cordoba M, Wolach B. Lymphocytic interstitial pneumonitis preceding polyarticular juvenile rheumatoid arthritis. Clin Exp Rheumatol. 1998;16:617–619
  18. Yood RA, Steigman DM, Gill LR. Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus. Lupus. 1995;4:161–163
  19. Benisch B, Peison B. The association of lymphocytic interstitial pneumonia and systemic lupus erythematosus. Mt Sinai J Med. 1979;46:341–398
  20. Travis WD, Fox CH, Devaney KO, et al. Lymphoid pneumonitis in 50 adult patients infected with the human immunodeficiency virus: lymphocytic interstitial pneumonitis versus nonspecific interstitial pneumonitis. Hum Pathol. 1992;23:529–541
  21. Grieco MH, Chinoy-Acharya P. Lymphocytic interstitial pneumonia associated with the acquired immune deficiency syndrome. Am Rev Respir Dis. 1985;131:952–955
  22. Morris JC, Rosen MJ, Marchevsky A, Teirstein AS. Lymphocytic interstitial pneumonia in patients at risk for the acquired immune deficiency syndrome. Chest. 1987;91:63–67
  23. Couderc LJ, Herve P, Solal-Celigny P, et al. Interstitial lymphoid pneumonia and polyadenopathies in patients infected with the LAV/HTLV III virus. Presse Med. 1986;15:1127–1130
  24. Kohler PF, Cook RD, Brown WR, Manguso RL. Common variable hypogammaglobulinemia with T-cell nodular lymphoid interstitial pneumonitis and B-cell nodular lymphoid hyperplasia: different lymphocyte populations with a similar response to prednisone therapy. J Allergy Clin Immunol. 1982;70:299–305
  25. Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR Morb Mortal Wkly Rep. 1987;36:225–230235–226
  26. Johkoh T, Muller NL, Pickford HA, et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology. 1999;212:567–572
  27. Silva CI, Flint JD, Levy RD, Muller NL. Diffuse lung cysts in lymphoid interstitial pneumonia: high-resolution CT and pathologic findings. J Thorac Imaging. 2006;21:241–244
  28. Teruya-Feldstein J, Kingma DW, Weiss A, et al. Chemokine gene expression and clonal analysis of B cells in tissues involved by lymphoid interstitial pneumonitis from HIV-infected pediatric patients. Mod Pathol. 2001;14:929–936
  29. Addis BJ, Hyjek E, Isaacson PG. Primary pulmonary lymphoma: a re- appraisal of its histogenesis and its relationship to pseudolyphoma and lymphoid interstitial pneumonitis. Histopathology. 1988;13:1–17
  30. Abbondanzo SL, Rush W, Bijwaard KE, Koss MN. Nodular lymphoid hyperplasia of the lung: a clinicopathologic study of 14 cases. Am J Surg Pathol. 2000;24:587–597
  31. Bienenstock J, McDermott MR, Befus AD. The significance of bronchus-associated lymphoid tissue. Bull Eur Physiopathol Respir. 1982;18:153–177
  32. Harris NL. Extranodal lymphoid infiltrates and mucosa-associated lymphoid tissue (MALT). Am J Surg Pathol. 1991;15:879–884
  33. Jaffe ES. Common threads of mucosa-associated lymphoid tissue lymphoma pathogenesis: from infection to translocation. J Natl Cancer Inst. 2004;96:571–573
  34. Kurtin PJ, Myers JL, Adlakha H, et al. Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol. 2001;25:997–1008
  35. Isaacson P, Wright DH. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer. 1984;53:2515–2524
  36. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 1983;52:1410–1416
  37. Isaacson PG, Muller-Hermelink HK, Piris MA, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In:  Jaffe ES,  Harris NL,  Stein H,  Vardiman JW editor. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue. World Health Organization Classification of Tumours. Lyon: IARC Press; 2001;p. 157–160
  38. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252–260
  39. Fiche M, Caprons F, Berger F, et al. Primary pulmonary non-Hodgkin’s lymphomas. Histopathology. 1995;26:529–537
  40. Nicholson AG, Wotherspoon AC, Diss TC, et al. Pulmonary B-cell non-Hodgkin’s lymphomas. The value of immunohistochemistry and gene analysis in diagnosis. Histopathology. 1995;26:395–403
  41. Cordier JF, Chailleux E, Lauque D, et al. Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients. Chest. 1993;103:201–208
  42. Li G, Hansmann ML, Zwingers T, Lennert K. Primary lymphomas of the lung: morphological, immunohistochemical and clinical features. Histopathology. 1990;16:519–531
  43. Isaacson PG, Wotherspoon AC, Diss T, Pan L. Follicular colonization in B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Surg Pathol. 1991;15:819–828
  44. Lim JK, Lacy MQ, Kurtin PJ, Kyle RA, Gertz MA. Pulmonary marginal zone lymphoma of MALT type as a cause of localised pulmonary amyloidosis. J Clin Pathol. 2001;54:642–646
  45. Dacic S, Colby TV, Yousem SA. Nodular amyloidoma and primary pulmonary lymphoma with amyloid production: a differential diagnostic problem. Mod Pathol. 2000;13:934–940
  46. Fairweather PM, Williamson R, Tsikleas G. Pulmonary extranodal marginal zone lymphoma with massive crystal storing histiocytosis. Am J Surg Pathol. 2006;30:262–267
  47. Zaer FS, Braylan RC, Zander DS, Iturraspe JA, Almasri NM. Multiparametric flow cytometry in the diagnosis and characterization of low-grade pulmonary mucosa-associated lymphoid tissue lymphomas. Mod Pathol. 1998;11:525–532
  48. de Leon ED, Alkan S, Huang JC, Hsi ED. Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin’s lymphomas of small lymphocytes. Mod Pathol. 1998;11:1046–1051
  49. Chen CC, Raikow RB, Sonmez-Alpan E, Swerdlow SH. Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel. Appl Immunohistochem Mol Morphol. 2000;8:1–11
  50. Kaplan MA, Pettit CL, Zukerberg LR, Harris NL. Primary lymphoma of the trachea with morphologic and immunophenotypic characteristics of low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Surg Pathol. 1992;16:71–75
  51. Okubo K, Miyamoto N, Komaki C. Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the trachea: a case of surgical resection and long term survival. Thorax. 2005;60:82–83
  52. Mitchell A, Meunier C, Ouellette D, Colby T. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with initial presentation in the pleura. Chest. 2006;129:791–794
  53. Hashemi SM, Heitbrink MA, Jiwa M, Boersma WG. A patient with endobronchial BALT lymphoma successfully treated with radiotherapy. Respir Med. 2007;101:2227–2229
  54. Ren Y, Raitz EN, Lee KR, Pingleton SK, Tawfik O. Pulmonary small lymphocytic lymphoma (mucosa-associated lymphoid tissue type) associated with pulmonary hyalinizing granuloma. Chest. 2001;120:1027–1030
  55. Joshi VV, Gagnon GA, Chadwick EG, et al. The spectrum of mucosa-associated lymphoid tissue lesions in pediatric patients infected with HIV: A clinicopathologic study of six cases. Am J Clin Pathol. 1997;107:592–600
  56. Teruya-Feldstein J, Temeck BK, Sloas MM, et al. Pulmonary malignant lymphoma of mucosa-associated lymphoid tissue (MALT) arising in a pediatric HIV-positive patient. Am J Surg Pathol. 1995;19:357–363
  57. Cortot AB, Cottin V, Issartel B, Meyronet D, Coiffier B, Cordier JF. Pulmonary MALT lymphoma revealing AIDS. Rev Mal Respir. 2006;23:353–357
  58. Streubel B, Simonitsch-Klupp I, Mullauer L, et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia. 2004;18:1722–1726
  59. Remstein ED, Kurtin PJ, Einerson RR, Paternoster SF, Dewald GW. Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MALT1. Leukemia. 2004;18:156–160
  60. Okabe M, Inagaki H, Ohshima K, et al. API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Pathol. 2003;162:1113–1122
  61. Akagi T, Motegi M, Tamura A, et al. A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene. 1999;18:5785–5794
  62. Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood. 1999;93:3601–3609
  63. Sagaert X, De Wolf-Peeters C, Noels H, Baens M. The pathogenesis of MALT lymphomas: where do we stand?. Leukemia. 2007;21:389–396
  64. Hosokawa Y, Seto M. Nuclear factor kappaB activation and antiapoptosis in mucosa-associated lymphoid tissue lymphoma. Int J Hematol. 2004;80:215–223
  65. Ho L, Davis RE, Conne B, et al. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood. 2005;105:2891–2899
  66. Liebow AA, Carrington CB, Friedman PJ. Lymphomatoid granulomatosis. Hum Pathol. 1972;3:457–558
  67. Katzenstein AL, Carrington CB, Liebow AA. Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer. 1979;43:360–373
  68. Koss MN, Hochholzer L, Langloss JM, Wehunt WD, Lazarus AA, Nichols PW. Lymphomatoid granulomatosis: A clinicopathologic study of 42 patients. Pathology. 1986;18:283–288
  69. Fauci AS, Haynes BF, Costa J, Katz P, Wolff SM. Lymphomatoid granulomatosis. Prospective clinical and therapeutic experience over 10 years. N Engl J Med. 1982;306:68–74
  70. Ilowite NT, Fligner CL, Ochs HD, et al. Pulmonary angiitis with atypical lymphoreticular infiltrates in Wiskott-Aldrich syndrome: possible relationship of lymphomatoid granulomatosis and EBV infection. Clin Immunol Immunopathol. 1986;41:479–484
  71. Mittal K, Neri A, Feiner H, Schinella R, Alfonso F. Lymphomatoid granulomatosis in the acquired immunodeficiency syndrome. Evidence of Epstein-Barr virus infection and B-cell clonal selection without myc rearrangement. Cancer. 1990;65:1345–1349
  72. Haque AK, Myers JL, Hudnall SD, et al. Pulmonary lymphomatoid granulomatosis in acquired immunodeficiency syndrome: lesions with Epstein-Barr virus infection. Mod Pathol. 1998;11:347–356
  73. Hammar S, Mennemeyer R. Lymphomatoid granulomatosis in a renal transplant recipient. Hum Pathol. 1976;7:111–116
  74. Walter M, Thomson NM, Dowling J, Fox R, Atkins RC. Lymphomatoid granulomatosis in a renal transplant recipient. Aust N Z J Med. 1979;9:434–436
  75. Michaud J, Banerjee D, Kaufmann JC. Lymphomatoid granulomatosis involving the central nervous system: complication of a renal transplant with terminal monoclonal B-cell proliferation. Acta Neuropathol (Berl). 1983;61:141–147
  76. Lee JS, Tuder R, Lynch DA. Lymphomatoid granulomatosis: radiologic features and pathologic correlations. AJR Am J Roentgenol. 2000;175:1335–1339
  77. Ishii H, Kishi K, Kushima H, et al. Pulmonary lymphomatoid granulomatosis radiologically mimicking interstitial pneumonia. Nihon Kokyuki Gakkai Zasshi. 2007;45:483–488
  78. Lipford EH, Margolick JB, Longo DL, Fauci AS, Jaffe ES. Angiocentric immunoproliferative lesions: A clinicopathologic spectrum of post-thymic T-cell proliferations. Blood. 1988;72:1674–1681
  79. Guinee D, Jaffe E, Kingma D, et al. Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. Am J Surg Pathol. 1994;18:753–764
  80. Wilson WH, Kingma DW, Raffeld M, Wittes RE, Jaffe ES. Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b. Blood. 1996;87:4531–4537
  81. Myers JL, Kurtin PJ, Katzenstein ALA, et al. Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection. Am J Surg Pathol. 1995;19:1300–1312
  82. Nicholson AG, Wotherspoon AC, Diss TC, et al. Lymphomatoid granulomatosis: evidence that some cases represent Epstein-Barr virus-associated B-cell lymphoma. Histopathology. 1996;29:317–324
  83. McNiff JM, Cooper D, Howe G, et al. Lymphomatoid granulomatosis of the skin and lung. An angiocentric T-cell-rich B-cell lymphoproliferative disorder. Arch Dermatol. 1996;132:1464–1470
  84. Taniere P, Thivolet-Bejui F, Vitrey D, et al. Lymphomatoid granulomatosis-a report on four cases: evidence for B phenotype of the tumoral cells. Eur Respir J. 1998;12:102–106
  85. Jaffe ES, Wilson WH. Lymphomatoid granulomatosis: pathogenesis, pathology and clinical implications. Cancer Surv. 1997;30:233–248
  86. Guinee DG, Perkins SL, Travis WD, Holden JA, Tripp SR, Koss MN. Proliferation and cellular phenotype in lymphomatoid granulomatosis. Implications of a higher proliferation index in B cells. Am J Surg Pathol. 1998;22:1093–1100
  87. Shimada K, Matsui T, Kawakami M, et al. Methotrexate-related lymphomatoid granulomatosis: a case report of spontaneous regression of large tumours in multiple organs after cessation of methotrexate therapy in rheumatoid arthritis. Scand J Rheumatol. 2007;36:64–67
  88. Kameda H, Okuyama A, Tamaru J, Itoyama S, Iizuka A, Takeuchi T. Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis. Clin Rheumatol. 2007;26:1585–1589
  89. Sordillo PP, Epremian B, Koziner B, Lacher M, Lieberman P. Lymphomatoid granulomatosis. An analysis of clinical and immunologic characteristics. Cancer. 1982;49:2070–2076
  90. Oyama T, Yamamoto K, Asano N, et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res. 2007;13:5124–5132
  91. James WD, Odom RB, Katzenstein A-LA. Cutaneous manifestations of lymphomatoid granulomatosis. Report of 44 cases and a review of the literature. Arch Dermatol. 1981;117:196–202
  92. Richter C, Schnabel A, Muller KM, Reuter M, Schuster P, Gross WL. Lymphomatoid granulomatosis-remission induction with interferon-alpha 2b. Dtsch Med Wochenschr. 1997;122:1106–1110
  93. Zaidi A, Kampalath B, Peltier WL, Vesole DH. Successful treatment of systemic and central nervous system lymphomatoid granulomatosis with rituximab. Leuk Lymphoma. 2004;45:777–780
  94. Jordan K, Grothey A, Grothe W, Kegel T, Wolf HH, Schmoll HJ. Successful treatment of mediastinal lymphomatoid granulomatosis with rituximab monotherapy. Eur J Haematol. 2005;74:263–266
  95. Moudir-Thomas C, Foulet-Roge A, Plat M, et al. Efficacy of rituximab in lymphomatoid granulomatosis. Rev Mal Respir. 2004;21:1157–1161
  96. Robak T, Kordek R, Urbanska-Rys H, et al. High activity of rituximab combined with cladribine and cyclophosphamide in a patient with pulmonary lymphomatoid granulomatosis and bone marrow involvement. Leuk Lymphoma. 2006;47:1667–1669
  97. Hu YH, Liu CY, Chiu CH, Hsiao LT. Successful treatment of elderly advanced lymphomatoid granulomatosis with rituximab-CVP combination therapy. Eur J Haematol. 2007;78:176–177
  98. Harris NL, Swerdlow SH, Frizzera G, Knowles DM. Post-transplant lymphoproliferative disorders. In:  Jaffe ES,  Harris NL,  Stein H,  Vardiman JW editor. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue. World Health Organization Classification of Tumours. Lyon: IARC Press; 2001;p. 264–269
  99. Nelson BP, Nalesnik MA, Bahler DW, Locker J, Fung JJ, Swerdlow SH. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?. Am J Surg Pathol. 2000;24:375–385
  100. Curtis RE, Travis LB, Rowlings PA, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999;94:2208–2216
  101. Walker RC, Paya CV, Marshall WF, et al. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant. 1995;14:214–221
  102. Walker RC, Marshall WF, Strickler JG, et al. Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis. 1995;20:1346–1353
  103. Nalesnik MA. Clinicopathologic characteristics of post-transplant lymphoproliferative disorders. Recent Results Cancer Res. 2002;159:9–18
  104. Halkos ME, Miller JI, Mann KP, Miller DL, Gal AA. Thoracic presentations of posttransplant lymphoproliferative disorders. Chest. 2004;126:2013–2020
  105. Yousem SA, Randhawa P, Locker J, et al. Posttransplant lymphoproliferative disorders in heart-lung transplant recipients. Hum Pathol. 1989;20:361–369
  106. Ramalingam P, Rybicki L, Smith MD, et al. Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience. Mod Pathol. 2002;15:647–656
  107. Carignan S, Staples CA, Muller NL. Intrathoracic lymphoproliferative disorders in the immunocompromised patient: CT findings. Radiology. 1995;197:53–58
  108. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 1995;85:552–565
  109. Chadburn A, Chen JM, Hsu DT, et al. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant. Cancer. 1998;82:1978–1987
  110. Knowles DM. Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol. 1999;12:200–217
  111. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol. 1988;133:173–192
  112. Shapiro RS, McClain K, Frizzera G, et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood. 1988;71:1234–1243
  113. Cleary ML, Warnke R, Sklar J. Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements. N Engl J Med. 1984;310:477–482
  114. Ferry JA, Jacobson JO, Conti D, Delmonico F, Harris NL. Lymphoproliferative disorders and hematologic malignancies following organ transplantation. Mod Pathol. 1989;2:583–592
  115. Craig FE, Gulley ML, Banks PM. Posttransplantation lymphoproliferative disorders. Am J Clin Pathol. 1993;99:265–276
  116. Oertel SH, Verschuuren E, Reinke P, et al. Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transplant. 2005;5:2901–2906
  117. Knoop C, Kentos A, Remmelink M, et al. Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission. Clin Transplant. 2006;20:179–187
  118. Cadranel J, Wislez M, Antoine M. Primary pulmonary lymphoma. Eur Respir J. 2002;20:750–762
  119. Nicholson AG, Harris NL. Primary pulmonary diffuse large B-cell lymphoma. In:  Travis WD,  Brambilla E,  Müller-Hermelink HK,  Harris CC editor. Pathology and Genetic of Tumours of the Lung, Pleura, Thymus and Heart World Health Organization Classification of Tumours. Lyon: IARC Press; 2004;p. 91
  120. Ray P, Antoine M, Mary-Krause M, et al. AIDS-related primary pulmonary lymphoma. Am J Respir Crit Care Med. 1998;158:1221–1229
  121. Polish LB, Cohn DL, Ryder JW, Myers AM, O’Brien RF. Pulmonary non-Hodgkin’s lymphoma in AIDS. Chest. 1989;96:1321–1326
  122. L’Hoste RJ, Filippa DA, Lieberman PH, Bretsky S. Primary pulmonary lymphomas. A clinicopathologic analysis of 36 cases. Cancer. 1984;54:1397–1984
  123. Colby TV, Hoppe RT, Warnke RA. Hodgkin’s disease at autopsy: 1972–1977. Cancer. 1981;47:1852–1862
  124. Radin AI. Primary pulmonary Hodgkin’s disease. Cancer. 1990;65:550–563
  125. Yousem SA, Weiss LM, Colby TV. Primary pulmonary Hodgkin’s disease. Cancer. 1986;57:1217–1224
  126. Cartier Y, Johkoh T, Honda O, Muller NL. Primary pulmonary Hodgkin’s disease: CT findings in three patients. Clin Radiol. 1999;54:182–184
  127. Rodriguez J, Tirabosco R, Pizzolitto S, Rocco M, Falconieri G. Hodgkin lymphoma presenting with exclusive or preponderant pulmonary involvement: a clinicopathologic study of 5 new cases. Ann Diagn Pathol. 2006;10:83–88
  128. Chetty R, Slavin JL, O’Leary JJ, Ansari NA, Gatter KC. Primary Hodgkin’s disease of the lung. Pathology. 1995;27:111–114
  129. Vassallo J, Lamant L, Brugieres L, et al. ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin’s lymphoma: report of 10 cases. Am J Surg Pathol. 2006;30:223–229
  130. Gatter KC, Warnke RA. Intravascular large B-cell lymphoma. In:  Jaffe ES,  Harris NL,  Stein H,  Vardiman W editor. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue. World Health Organization Classification of Tumours. Lyon: IARC Press; 2001;p. 177–178
  131. Yousem SA, Colby TV. Intravascular lymphomatosis presenting in the lung. Cancer. 1990;65:349–353
  132. Ko YH, Han JH, Go JH, et al. Intravascular lymphomatosis: a clinicopathological study of two cases presenting as an interstitial lung disease. Histopathology. 1997;31:555–562
  133. Martusewicz-Boros M, Wiatr E, Radzikowska E, Roszkowski-Sliz K, Langfort R. Pulmonary intravascular large B-cell lymphoma as a cause of severe hypoxemia. J Clin Oncol. 2007;25:2137–2139
  134. Takamura K, Nasuhara Y, Mishina T, et al. Intravascular lymphomatosis diagnosed by transbronchial lung biopsy. Eur Respir J. 1997;10:955–957
  135. Owa M, Koyama J, Asakawa K, Hikita H, Kubo K, Ikeda SI. Intravascular lymphomatosis presenting as reversible severe pulmonary hypertension. Int J Cardiol. 2000;75:283–284
  136. Yamagata T, Okamoto Y, Ota K, Katayama N, Tsuda T, Yukawa S. A case of pulmonary intravascular lymphomatosis diagnosed by thoracoscopic lung biopsy. Respiration. 2003;70:414–418
  137. Matsue K, Takeuchi M, Uryu H, Koseki M, Asada N, Kaneko Y. Rapid improvement of hypoxemia by the use of rituximab in patients with pulmonary intravascular lymphoma. Leuk Lymphoma. 2007;48:197–200
  138. Snyder LS, Harmon KR, Estensen RD. Intravascular lymphomatosis (malignant angioendotheliomatosis) presenting as pulmonary hypertension. Chest. 1989;96:1199–1200
  139. Evert M, Lehringer-Polzin M, Mobius W, Pfeifer U. Angiotropic large-cell lymphoma presenting as pulmonary small vessel occlusive disease. Hum Pathol. 2000;31:879–882
  140. Gabor EP, Sherwood T, Mercola KE. Intravascular lymphomatosis presenting as adult respiratory distress syndrome. Am J Hematol. 1997;56:155–160
  141. Sukpanichnant S, Visuthisakchai S. Intravascular lymphomatosis: a study of 20 cases in Thailand and a review of the literature. Clin Lymphoma Myeloma. 2006;6:319–328
  142. Takahashi E, Kajimoto K, Fukatsu T, Yoshida M, Eimoto T, Nakamura S. Intravascular large T-cell lymphoma: a case report of CD30-positive and ALK-negative anaplastic type with cytotoxic molecule expression. Virchows Arch. 2005;447:1000–1006
  143. Williams G, Foyle A, White D, Greer W, Burrell S, Couban S. Intravascular T-cell lymphoma with bowel involvement: case report and literature review. Am J Hematol. 2005;78:207–211
  144. Ponzoni M, Arrigoni G, Gould VE, et al. Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol. 2000;31:220–226
  145. Berkman N, Breuer R, Kramer MR, Polliack A. Pulmonary involvement in lymphoma. Leuk Lymphoma. 1996;20:229–237
  146. Green RA, Nichols NJ. Pulmonary involvement in leukemia. Am Rev Respir Dis. 1959;80:833–844
  147. Hildebrand FL, Rosenow EC, Habermann TM, Tazelaar HD. Pulmonary complications of leukemia. Chest. 1990;98:1233–1239
  148. Costa MB, Siqueira SA, Saldiva PH, Rabe KF, Mauad T. Histologic patterns of lung infiltration of B-cell, T-cell, and Hodgkin lymphomas. Am J Clin Pathol. 2004;121:718–726
  149. Lewis ER, Caskey CI, Fishman EK. Lymphoma of the lung: CT findings in 31 patients. AJR Am J Roentgenol. 1991;156:711–714
  150. Tanaka N, Matsumoto T, Miura G, et al. CT findings of leukemic pulmonary infiltration with pathologic correlation. Eur Radiol. 2002;12:166–174
  151. Heyneman LE, Johkoh T, Ward S, Honda O, Yoshida S, Muller NL. Pulmonary leukemic infiltrates: high-resolution CT findings in 10 patients. AJR Am J Roentgenol. 2000;174:517–521
  152. Tryka AF, Godleski JJ, Fanta CH. Leukemic cell lysis pneumonopathy. A complication of treated myeloblastic leukemia. Cancer. 1982;50:2763–2770
  153. Koh TT, Colby TV, Muller NL. Myeloid leukemias and lung involvement. Semin Respir Crit Care Med. 2005;26:514–519
  154. Callahan M, Wall S, Askin F, Delaney D, Koller C, Orringer EP. Granulocytic sarcoma presenting as pulmonary nodules and lymphadenopathy. Cancer. 1987;60:1902–1904
  155. Stafford CM, Herndier B, Yi ES, Weidner N, Harrell JH. Granulocytic sarcoma of the tracheobronchial tree: bronchoscopic and pathologic correlation. Respiration. 2004;71:529–532
  156. Hicklin GA, Drevyanko TF. Primary granulocytic sarcoma presenting with pleural and pulmonary involvement. Chest. 1988;94:655–656
  157. Philippe B, Delfau-Larue MH, Epardeau B, et al. B-cell pulmonary lymphoma: gene rearrangement analysis of bronchoalveolar lymphocytes by polymerase chain reaction. Chest. 1999;115:1242–1247
  158. Zompi S, Couderc LJ, Cadranel J, et al. Clonality analysis of alveolar B lymphocytes contributes to the diagnostic strategy in clinical suspicion of pulmonary lymphoma. Blood. 2004;103:3208–3215
  159. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995;332:1186–1191
  160. Nador RG. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpes virus. Blood. 1996;88:645–656
  161. Ansari MQ, Dawson DB, Nador R, et al. Primary body cavity-based AIDS-related lymphomas. Am J Clin Pathol. 1996;105:221–229
  162. Knowles DM, Inghirami G, Ubriaco A, Dalla-Favera R. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood. 1989;73:792–799
  163. Carbone A, Gloghini A, Vaccher E, et al. Kaposi’s sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions. Br J Haematol. 1996;94:533–543
  164. Ferrozzi F, Tognini G, Mulonzia NW, Bova D, Pavone P. Primary effusion lymphomas in AIDS: CT findings in two cases. Eur Radiol. 2001;11:623–625
  165. Morassut S, Vaccher E, Balestreri L, et al. HIV-associated human herpesvirus 8-positive primary lymphomatous effusions: radiologic findings in six patients. Radiology. 1997;205:459–463
  166. Munichor M, Cohen H, Sarid R, Manov I, Iancu TC. Human herpesvirus 8 in primary effusion lymphoma in an HIV-seronegative male. A case report. Acta Cytol. 2004;48:425–430
  167. Cobo F, Hernandez S, Hernandez L, et al. Expression of potentially oncogenic HHV-8 genes in an EBV-negative primary effusion lymphoma occurring in an HIV-seronegative patient. J Pathol. 1999;189:288–293
  168. Teruya-Feldstein J, Zauber P, Setsuda JE, et al. Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman’s disease and primary effusion lymphoma. Lab Invest. 1998;78:1637–1642
  169. Said JW, Tasaka T, Takeuchi S, et al. Primary effusion lymphoma in women: report of two cases of Kaposi’s sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood. 1996;88:3124–3128
  170. Shirokov D, Kadyrova E, Anokhina M, et al. A case of HHV-8-associated HIV-negative primary effusion lymphoma in Moscow. J Med Virol. 2007;79:270–277
  171. Huang Q, Chang KL, Gaal K, Arber DA. Primary effusion lymphoma with subsequent development of a small bowel mass in an HIV-seropositive patient: a case report and literature review. Am J Surg Pathol. 2002;26:1363–1367
  172. Carbone A, Gloghini A, Vaccher E, et al. Kaposi’s sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma. J Mol Diagn. 2005;7:17–27
  173. Licci S, Narciso P, Morelli L, et al. Primary effusion lymphoma in pleural and pericardial cavities with multiple solid nodal and extra-nodal involvement in a human immunodeficiency virus-positive patient. Leuk Lymphoma. 2007;48:209–211
  174. Klein U, Gloghini A, Gaidano G, et al. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood. 2003;101:4115–4121
  175. Carbone A, Gloghini A. HHV-8-associated lymphoma: state-of-the-art review. Acta Haematol. 2007;117:129–131
  176. Deloose ST, Smit LA, Pals FT, Kersten MJ, van Noesel CJ, Pals ST. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma. Leukemia. 2005;19:851–855
  177. Du MQ, Bacon CM, Isaacson PG. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders. J Clin Pathol. 2007;60:1350–1357
  178. Chadburn A, Hyjek E, Mathew S, Cesarman E, Said J, Knowles DM. KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol. 2004;28:1401–1416
  179. Lechapt-Zalcman E, Challine D, Delfau-Larue MH, Haioun C, Desvaux D, Gaulard P. Association of primary pleural effusion lymphoma of T-cell origin and human herpesvirus 8 in a human immunodeficiency virus-seronegative man. Arch Pathol Lab Med. 2001;125:1246–1248
  180. Shimazaki M, Fujita M, Tsukamoto K, et al. An unusual case of primary effusion lymphoma in a HIV-negative patient not pathogenetically associated with HHV8. Eur J Haematol. 2003;71:62–67
  181. Hisamoto A, Yamane H, Hiraki A, et al. Human herpes virus-8-negative primary effusion lymphoma in a patient with common variable immunodeficiency. Leuk Lymphoma. 2003;44:2019–2022
  182. Kobayashi Y, Kamitsuji Y, Kuroda J, et al. Comparison of human herpes virus 8 related primary effusion lymphoma with human herpes virus 8 unrelated primary effusion lymphoma-like lymphoma on the basis of HIV: report of 2 cases and review of 212 cases in the literature. Acta Haematol. 2007;117:132–144
  183. Banks PM, Warnke RA. Primary effusion lymphoma. In:  Jaffe ES,  Harris NL,  Stein H,  Vardiman JW editor. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue. World Health Organization Classification of Tumours. Lyon: IARC Press; 2001;p. 179–180
  184. Karcher DS, Alkan S. Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: a unique B-cell neoplasm. Hum Pathol. 1997;28:801–808
  185. Brimo F, Michel RP, Khetani K, Auger M. Primary effusion lymphoma: a series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis. Cancer. 2007;111:224–233
  186. Gaidano G, Gloghini A, Gattei V, et al. Association of Kaposi’s sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen. Blood. 1997;90:4894–4900
  187. Carbone A, Gloghini A, Cozzi MR, et al. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis. Br J Haematol. 2000;111:247–257
  188. Dupin N, Fisher C, Kellam P, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi’s sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma. Proc Natl Acad Sci USA. 1999;96:4546–4551
  189. Horenstein MG, Nador RG, Chadburn A, et al. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi’s sarcoma-associated herpesvirus/human herpesvirus-8. Blood. 1997;90:1186–1191
  190. Teruya-Feldstein J. Diffuse large B-cell lymphomas with plasmablastic differentiation. Curr Oncol Rep. 2005;7:357–363
  191. Boulanger E, Daniel MT, Agbalika F, Oksenhendler E. Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma. Am J Hematol. 2003;73:143–148
  192. Iuchi K, Ichimiya A, Akashi A, et al. Non-Hodgkin’s lymphoma of the pleural cavity developing from long-standing pyothorax. Cancer. 1987;60:1771–1775
  193. Iuchi K, Aozasa K, Yamamoto S, et al. Non-Hodgkin’s lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases. Jpn J Clin Oncol. 1989;19:249–257
  194. Nakatsuka S, Yao M, Hoshida Y, Yamamoto S, Iuchi K, Aozasa K. Pyothorax-associated lymphoma: a review of 106 cases. J Clin Oncol. 2002;20:4255–4260
  195. Aozasa K, Takakuwa T, Nakatsuka S. Pyothorax-associated lymphoma: a lymphoma developing in chronic inflammation. Adv Anat Pathol. 2005;12:324–331
  196. Martin A, Capron F, Liguory-Brunaud MD, De Frejacques C, Pluot M, Diebold J. Epstein-Barr virus-associated primary malignant lymphomas of the pleural cavity occurring in longstanding pleural chronic inflammation. Hum Pathol. 1994;25:1314–1318
  197. Petitjean B, Jardin F, Joly B, et al. Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype. Am J Surg Pathol. 2002;26:724–732
  198. Fukayama M, Ibuka T, Hayashi Y, Ooba T, Koike M, Mizutani S. Epstein-Barr virus in pyothorax-associated pleural lymphoma. Am J Pathol. 1993;143:1044–1049
  199. Sasajima Y, Yamabe H, Kobashi Y, Hirai K, Mori S. High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas. Am J Pathol. 1993;143:1280–1285
  200. Banks PM, Harris NL, Warnke RA, Gaulard P. Lymphomas. In:  Travis WD,  Brambilla E,  Müller-Hermelink HK,  Harris CC editor. Pathology and Genetic of Tumours of the Lung, Pleura, Thymus and Heart World Health Organization Classification of Tumours. Lyon: IARC Press; 2004;p. 137–140
  201. Parisio E, Bianchi C, Rovej R, Sparacio F, Ferrari A, Scanni A. Pulmonary asbestosis associated to pleural non-Hodgkin lymphoma. Tumori. 1999;85:75–77
  202. Narimatsu H, Ota Y, Kami M, et al. Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients. Ann Oncol. 2007;18:122–128
  203. Mori N, Yatabe Y, Narita M, Kobayashi T, Asai J. Pyothorax-associated lymphoma. An unusual case with biphenotypic character of T and B cells. Am J Surg Pathol. 1996;20:760–766
  204. Yang HB, Li J, Shen T. Primary anaplastic large cell lymphoma of the lung. Report of two cases and literature review. Acta Haematol. 2007;118:188–191
  205. Guerra J, Echevarria-Escudero M, Barrio N, Velez-Rosario R. Primary endobronchial anaplastic large cell lymphoma in a pediatric patient. P R Health Sci J. 2006;25:159–161
  206. Rush WL, Andriko JA, Taubenberger JK, et al. Primary anaplastic large cell lymphoma of the lung: a clinicopathologic study of five patients. Mod Pathol. 2000;13:1285–1292
  207. Delsol G, Ralfkiaer E, Stein H, Wright D, Jaffe ES. Anaplastic large cell lymphoma. In:  Jaffe ES,  Harris NL,  Stein H,  Vardiman JW editor. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue World Health Organization Classification of Tumours. Lyon: IARC Press; 2001;p. 230–235
  208. Falini B, Pileri S, Stein H, et al. Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki1)-positive anaplastic large-cell lymphoma: implications for the differential diagnosis between lymphoid and nonlymphoid malignancies. Hum Pathol. 1990;21:624–629
  209. Koss MN, Hochholzer L, Moran CA, Frizzera G. Pulmonary plasmacytomas: a clinicopathologic and immunohistochemical study of five cases. Ann Diagn Pathol. 1998;2:1–11
  210. Wise JN, Schaefer RF, Read RC. Primary pulmonary plasmacytoma: a case report. Chest. 2001;120:1405–1407
  211. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol. 1990;7:19–73
  212. Ohori NP, Yu J, Landreneau RJ, Thaete FL, Kane K. Rosai-Dorfman disease of the pleura: a rare extranodal presentation. Hum Pathol. 2003;34:1210–1211

PII: S1756-2317(08)00119-9

doi: 10.1016/j.mpdhp.2008.07.008

Diagnostic Histopathology
Volume 14, Issue 10 , Pages 474-498 , October 2008

Article Tools

* Image Usage & Resolution